US2003175830A1PendingUtilityA1
Reagents and methods for the screening of compounds useful in the treatment of neurological diseases
Est. expiryJul 27, 2018(expired)· nominal 20-yr term from priority
C07K 14/4702A61K 38/00
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to the gene sequence of a novel transcription factor specific for central 5-HT (serotonergic) neurons. The sequence and products are useful in screening methods for identifying and testing agonists and antagonists of seronergic activity.
Claims
exact text as granted — not AI-modified1 . A method, comprising:
a) providing:
i) cells, and ii) an expression construct comprising SEQ ID NO:1; and
b) transfecting said cells with said expression construct so as to generate transfected cells.
2 . The method of claim 1 , further comprising c) culturing said cells under conditions such that serotonin release is detected.
3 . The method of claim 1 , further comprising c) culturing said cells under conditions such that seronergic receptor generation is detected.
4 . The method of claim 1 , further comprising c) contacting said transfected cells with a test compound.Join the waitlist — get patent alerts
Track US2003175830A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.